Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cell Calcium|April 21, 2009
Unique isoform-specific properties of calsequestrin in the heart and skeletal muscleLan Wei, Amy D Hanna, Nicole A Beard, et al.Skeletal Muscle|November 17, 2020
MyoSight-semi-automated image analysis of skeletal muscle cross sectionsLyle W Babcock, Amy D Hanna, Nadia H Agha, et al.Molecular Pharmacology|August 10, 2014
Adverse effects of doxorubicin and its metabolic product on cardiac RyR2 and SERCA2AAmy D Hanna, Alex Lam, Steffi Tham, et al.Molecular Pharmacology|June 24, 2011
Multiple actions of the anthracycline daunorubicin on cardiac ryanodine receptorsAmy D Hanna, Marie Janczura, Eric Cho, et al.Molecular Pharmacology|September 17, 2017
The Anthracycline Metabolite Doxorubicinol Abolishes RyR2 Sensitivity to Physiological Changes in Luminal Ca<sup>2+</sup> through an Interaction with CalsequestrinAmy D Hanna, Alexander Lam, Chris Thekkedam, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2021
Pathological mechanisms of vacuolar aggregate myopathy arising from a Casq1 mutationAmy D Hanna, Chang Seok Lee, Lyle Babcock, et al.Journal of Cell Science|August 23, 2014
Cardiac ryanodine receptor activation by a high Ca²⁺ store load is reversed in a reducing cytoplasmic redox environmentAmy D Hanna, Alex Lam, Chris Thekkedam, et al.Clinical and Experimental Pharmacology & Physiology|April 25, 2012
Proteins within the intracellular calcium store determine cardiac RyR channel activity and cardiac outputAngela F Dulhunty, Elize Wium, Linwei Li, et al.The Journal of General Physiology|December 11, 2024
Mechanisms underlying dilated cardiomyopathy associated with FKBP12 deficiencyAmy D Hanna, Ting Chang, Kevin S Ho, et al.Nature Communications|March 25, 2017
A chemical chaperone improves muscle function in mice with a RyR1 mutationChang Seok Lee, Amy D Hanna, Hui Wang, et al.Pageof 2